IDx-DR

What it does

IDx-DR (now EyeDiagnosis.net, acquired by Digital Diagnostics) is the first AI diagnostic system authorized by the FDA that can make a positive diagnosis without the need for a clinician to interpret the image. The system analyzes retinal photographs taken with a fundus camera to autonomously detect more-than-mild diabetic retinopathy - returning either a positive finding (refer to eye care specialist) or negative finding (rescreen in 12 months) without requiring an ophthalmologist to interpret each image. This autonomous AI diagnostic capability enables diabetic retinopathy screening to happen in primary care settings, increasing access to screening for the 34 million Americans with diabetes.

Strengths

• Primary care practices, diabetes clinics, and community health centers use IDx-DR for point-of-care diabetic retinopathy screening - autonomous AI diagnosis enabling screening where ophthalmologists are not available.
• Large health systems and accountable care organizations use IDx-DR to scale diabetic eye disease screening - AI enabling primary care to deliver retinopathy screening as part of routine diabetes management without specialist referral for every patient.
• IDx-DR (now EyeDiagnosis.net, acquired by Digital Diagnostics) is the first AI diagnostic system authorized by the FDA that can make a positive diagnosis without the need for a clinician to interpret the image.

Watch-outs

• Diabetic retinopathy detection only: IDx-DR is authorized specifically for detecting more-than-mild diabetic retinopathy — it does not diagnose other eye diseases and does not replace comprehensive ophthalmologic examination.
• Requires fundus camera hardware: IDx-DR requires specific compatible fundus cameras to capture retinal images — healthcare settings without this imaging equipment must invest in hardware alongside the AI software.
• Positive findings still require ophthalmologist follow-up: IDx-DR autonomously identifies patients who need referral but a positive result still requires in-person ophthalmologic evaluation — AI identifies who needs specialist care, not what treatment they need.

Pricing

IDx-DR pricing based on number of screenings. Per-screening fee model. Enterprise health system contracts negotiated. Annual contracts.